&Partners’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
&Partners's ABEV Position: Q2 2026 in Review
&Partners increased its Ambev (ABEV) stake by 16% in Q2 2026, buying an estimated $22.3K and bringing the position to 51,870 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.
&Partners first reported a position in ABEV in Q1 2025 and has held it in 6 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- &Partners held 51,870 shares of Ambev worth $163K as of Q2 2026.
- &Partners bought 7,144 Ambev shares in Q2 2026, an estimated $22.3K.
- Ambev made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2416 holding.
- &Partners first reported a position in Ambev in Q1 2025 and has held it in 6 quarters since.
- 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.